1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS (TM), a multimodal AI model that achieves state-of-the-art ...
Cell-Based Assay Platforms are Evolving to Meet Diverse Challenges Cell-based assay platforms are evolving to meet diverse challenges—mimicking disease states, preserving signaling pathways, modeling ...
SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...
Developing and validating appropriate biological assays can spell success or failure for biopharmaceutical products. Whether using live systems or biologically derived reagents, scientists must ...
Assessing the safety and efficacy of biotherapeutics is imperative during the drug development process. In particular, pharmacokinetic (PK) and anti-drug antibody (ADA) assays are conducted to study ...
Professor of Chemical and Biological Engineering, Biomedical Engineering, and Public Health, Colorado State University A vast number of chemicals are registered for production and use around the world ...
In a recent study posted to the medRxiv*preprint server, a team of researchers from Israel developed and validated novel reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR) assays ...
Before compounds can be used as medicines, they must go through rounds of testing. These can be separated into preclinical testing and clinical testing. Assays used in preclinical testing seek to test ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. "Some early [penicillin] assay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback